R.; FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma. Oncologist

NELARABINE FRONT-LINE THERAPY FOR ADULT T-LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA (T-LBL/ALL): PRELIMINARY RESULTS OF A SINGLE CENTRE EXPERIENCE

Sartor, C
Abbenante, M
Papayannidis, C
Iacobucci, I
Paolini, S
Ottaviani, E
Parisi, S
Ferrari, A
Guadagnuolo, V
Testoni, N
Cavo, M
Martinelli, G.
LONETTI, ANNALISA

January 2013

Background: Precursor T cell LBL/ALL occurs most frequently in late childhood, adolescence, and youn...

NELARABINE FRONT-LINE THERAPY FOR ADULT T-LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA (T-LBL/ALL): PRELIMINARY RESULTS OF A SINGLE CENTRE EXPERIENCE

Sartor, C
Abbenante, M
Papayannidis, C
Iacobucci, I
Paolini, S
Ottaviani, E
Lonetti, A
Parisi, S
Ferrari, A
Guadagnuolo, V
Testoni, N
Cavo, M
Martinelli, G

January 2013

Background: Precursor T cell LBL/ALL occurs most frequently in late childhood, adolescence, and youn...

A Review of Nelarabine in the Treatment of T-cell Lymphoblastic Leukemia/Lymphoma

Francisco J. Hernandez-Ilizaliturri
Myron S. Czuczman

January 2009

Patients with relapsed/refractory T-cell acute lymphocytic leukemia (T-ALL) and T-cell lymphoblastic...

FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia

Suzanne Demko
Jeffrey Summers
Patricia Keegan
Richard Pazdur
Suzanne Demko
Jeffrey Summers
Patricia Keegan
Richard Pazdur

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

January 1634

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

February 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

January 1634

located on the World Wide Web at: The online version of this article, along with updated information...

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 12:1247–1252

Bhupinder S. Mann
John R. Johnson
Martin H. Cohen
Robert Justice
Bhupinder S. Mann
John R. Johnson
Martin H. Cohen
Robert Justice
Richard Pazdur

January 2007

located on the World Wide Web at: The online version of this article, along with updated information...

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 12:1247–1252

Bhupinder S. Mann
John R. Johnson
Martin H. Cohen
Robert Justice
Bhupinder S. Mann
John R. Johnson
Martin H. Cohen
Robert Justice
Richard Pazdur

January 2007

located on the World Wide Web at: The online version of this article, along with updated information...

Nelarabine in the Treatment of Refractory T-Cell Malignancies

Andrew M. Roecker
Amy Stockert
David F. Kisor

January 2010

Nelarabine is a nucleoside analog indicated for the treatment of adult and pediatric patients with T...

Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia

Kelly M Reilly
David F Kisor

August 2009

Kelly M Reilly1, David F Kisor21Department of Pharmacy Practice, 2Department of Pharmaceutical and B...

Nelarabine: efficacy in the treatment of clinical malignancies

Roecker, Andrew M.
Allison, Jeffery C.
Kisor, David F.

August 2006

Nelarabine is a nucleoside analog prodrug of 9-beta-D-arabinofuranosylguanine. Nelarabine is indicat...

FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer

Richard Pazdur
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2004

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer

Richard Pazdur
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2004

located on the World Wide Web at: The online version of this article, along with updated information...

FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. Oncologist 14

Martin H. Cohen
Joe Gootenberg
Patricia Keegan
Richard Pazdur
Nonsquamous Non-small
Cell Lung Cancer
Non-small Cell
Lung Cancer
Martin H. Cohen
Joe Gootenberg
Patricia Keegan
Richard Pazdur

January 2009

located on the World Wide Web at: The online version of this article, along with updated information...

NELARABINE FRONT-LINE THERAPY FOR ADULT T-LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA (T-LBL/ALL): PRELIMINARY RESULTS OF A SINGLE CENTRE EXPERIENCE

Sartor, C
Abbenante, M
Papayannidis, C
Iacobucci, I
Paolini, S
Ottaviani, E
Parisi, S
Ferrari, A
Guadagnuolo, V
Testoni, N
Cavo, M
Martinelli, G.
LONETTI, ANNALISA

January 2013

Background: Precursor T cell LBL/ALL occurs most frequently in late childhood, adolescence, and youn...

NELARABINE FRONT-LINE THERAPY FOR ADULT T-LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA (T-LBL/ALL): PRELIMINARY RESULTS OF A SINGLE CENTRE EXPERIENCE

Sartor, C
Abbenante, M
Papayannidis, C
Iacobucci, I
Paolini, S
Ottaviani, E
Lonetti, A
Parisi, S
Ferrari, A
Guadagnuolo, V
Testoni, N
Cavo, M
Martinelli, G

January 2013

Background: Precursor T cell LBL/ALL occurs most frequently in late childhood, adolescence, and youn...

A Review of Nelarabine in the Treatment of T-cell Lymphoblastic Leukemia/Lymphoma

Francisco J. Hernandez-Ilizaliturri
Myron S. Czuczman

January 2009

Patients with relapsed/refractory T-cell acute lymphocytic leukemia (T-ALL) and T-cell lymphoblastic...

FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia

Suzanne Demko
Jeffrey Summers
Patricia Keegan
Richard Pazdur
Suzanne Demko
Jeffrey Summers
Patricia Keegan
Richard Pazdur

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

January 1634

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

February 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

January 1634

located on the World Wide Web at: The online version of this article, along with updated information...

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 12:1247–1252

Bhupinder S. Mann
John R. Johnson
Martin H. Cohen
Robert Justice
Bhupinder S. Mann
John R. Johnson
Martin H. Cohen
Robert Justice
Richard Pazdur

January 2007

located on the World Wide Web at: The online version of this article, along with updated information...

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 12:1247–1252

Bhupinder S. Mann
John R. Johnson
Martin H. Cohen
Robert Justice
Bhupinder S. Mann
John R. Johnson
Martin H. Cohen
Robert Justice
Richard Pazdur

January 2007

located on the World Wide Web at: The online version of this article, along with updated information...

Nelarabine in the Treatment of Refractory T-Cell Malignancies

Andrew M. Roecker
Amy Stockert
David F. Kisor

January 2010

Nelarabine is a nucleoside analog indicated for the treatment of adult and pediatric patients with T...

Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia

Kelly M Reilly
David F Kisor

August 2009

Kelly M Reilly1, David F Kisor21Department of Pharmacy Practice, 2Department of Pharmaceutical and B...

Nelarabine: efficacy in the treatment of clinical malignancies

Roecker, Andrew M.
Allison, Jeffery C.
Kisor, David F.

August 2006

Nelarabine is a nucleoside analog prodrug of 9-beta-D-arabinofuranosylguanine. Nelarabine is indicat...

FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer

Richard Pazdur
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2004

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer

Richard Pazdur
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2004

located on the World Wide Web at: The online version of this article, along with updated information...

FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme. Oncologist 14

Martin H. Cohen
Joe Gootenberg
Patricia Keegan
Richard Pazdur
Nonsquamous Non-small
Cell Lung Cancer
Non-small Cell
Lung Cancer
Martin H. Cohen
Joe Gootenberg
Patricia Keegan
Richard Pazdur

January 2009

located on the World Wide Web at: The online version of this article, along with updated information...

NELARABINE FRONT-LINE THERAPY FOR ADULT T-LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA (T-LBL/ALL): PRELIMINARY RESULTS OF A SINGLE CENTRE EXPERIENCE

Sartor, C
Abbenante, M
Papayannidis, C
Iacobucci, I
Paolini, S
Ottaviani, E
Parisi, S
Ferrari, A
Guadagnuolo, V
Testoni, N
Cavo, M
Martinelli, G.
LONETTI, ANNALISA

January 2013

Background: Precursor T cell LBL/ALL occurs most frequently in late childhood, adolescence, and youn...

NELARABINE FRONT-LINE THERAPY FOR ADULT T-LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA (T-LBL/ALL): PRELIMINARY RESULTS OF A SINGLE CENTRE EXPERIENCE

Sartor, C
Abbenante, M
Papayannidis, C
Iacobucci, I
Paolini, S
Ottaviani, E
Lonetti, A
Parisi, S
Ferrari, A
Guadagnuolo, V
Testoni, N
Cavo, M
Martinelli, G

January 2013

Background: Precursor T cell LBL/ALL occurs most frequently in late childhood, adolescence, and youn...

A Review of Nelarabine in the Treatment of T-cell Lymphoblastic Leukemia/Lymphoma

Francisco J. Hernandez-Ilizaliturri
Myron S. Czuczman

January 2009

Patients with relapsed/refractory T-cell acute lymphocytic leukemia (T-ALL) and T-cell lymphoblastic...

R.; FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma. Oncologist

Abstract

Extracted data

R.; FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma. Oncologist

Abstract

Extracted data

Related items

Related items